152 related articles for article (PubMed ID: 22615810)
1. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
[TBL] [Abstract][Full Text] [Related]
2. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
[TBL] [Abstract][Full Text] [Related]
3. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
[TBL] [Abstract][Full Text] [Related]
4. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
[TBL] [Abstract][Full Text] [Related]
5. HIV drug resistance early warning indicators in Namibia for public health action.
Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
[TBL] [Abstract][Full Text] [Related]
6. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
[TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
[TBL] [Abstract][Full Text] [Related]
8. [National profile of early warning indicators of HIV pharmaco-resistance in Cameroon].
Billong SC; Fokam J; Penda CI; Mvilongo EA; Fodjo R; Messeh A; Anoubissie JD; Kegne C; Nguekam G; Batamack YA; Billong EJ; Moutapam PR; Ndjolo A; Bonono L; Elat JB; Bissek ACZ
Pan Afr Med J; 2020; 37():374. PubMed ID: 33796187
[TBL] [Abstract][Full Text] [Related]
9. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
[TBL] [Abstract][Full Text] [Related]
10. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
[TBL] [Abstract][Full Text] [Related]
11. Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performance.
Billong SC; Fokam J; Aghokeng AF; Milenge P; Kembou E; Abessouguie I; Meva'a-Onglene FB; Bissek AC; Colizzi V; Mpoudi EN; Elat JB; Shiro KS
PLoS One; 2013; 8(8):e72680. PubMed ID: 23991142
[TBL] [Abstract][Full Text] [Related]
12. Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.
Fokam J; Nangmo A; Wandum C; Takou D; Santoro MM; Nlend AN; Ateba FN; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Lambo V; Fokunang C; Mbanya D; Colizzi V; Perno CF; Ndjolo A
AIDS Res Ther; 2020 May; 17(1):14. PubMed ID: 32398107
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
[TBL] [Abstract][Full Text] [Related]
14. Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.
Billong SC; Fokam J; Penda CI; Amadou S; Kob DS; Billong EJ; Colizzi V; Ndjolo A; Bisseck AZ; Elat JN
BMC Infect Dis; 2016 Nov; 16(1):678. PubMed ID: 27846809
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
[TBL] [Abstract][Full Text] [Related]
16. HIV drug resistance early warning indicators in Ethiopia: Variability at regional and health facility levels and trend over time.
Getaneh Y; Zealyas K; Adugna F; Kursha K; Atsbeha G/Egziabxier ; Kassa D; Assefa Y
Int J Infect Dis; 2020 Jun; 95():90-97. PubMed ID: 32088338
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of implementing an integrated tool for improvement of treatment quality and early-warning indicators for HIV drug resistance: a pilot study of centres in India.
Rewari BB; Seguy NS; Tanwar SS; Chan PL; Purohit V; Harvey P; Yu D; Rathore AS
WHO South East Asia J Public Health; 2015; 4(2):184-188. PubMed ID: 28607317
[TBL] [Abstract][Full Text] [Related]
19. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
